Administration of ALCAR after brain injury in rat pups improved long-term functional outcomes, including memory
As far as the vast majority of sporadic PD cases are concerned, the identification of susceptibility variants or heterozygous mutations of familial PD genes holds some promise for the future development of a genetic biomarker for PD, but for this, many large-scale statistically powered GWAS or other kinds of analyses would be necessary
Some preclinical data suggest neuroprotective activity in models of traumatic brain injury and peripheral nerve damage
Compounded GLP-1 FAQ By Patrick OBrien, JD, general counsel, and Kirstie Jackson, director of education, American Med Spa Association What is happening with glucagon-like peptide 1 (GLP-1) medications
The current certification is valid through December 31, 2026
Chris Serres: Mm-hmm